.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Cipla
Fish and Richardson
Novartis
Farmers Insurance
McKinsey
US Department of Justice
Julphar
Medtronic

Generated: November 20, 2017

DrugPatentWatch Database Preview

Alcon Company Profile

« Back to Dashboard

What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?

ALCON has forty-six approved drugs.

There is one US patent protecting ALCON drugs. There is one tentative approval on ALCON drugs.

There are eighteen patent family members on ALCON drugs in sixteen countries and thirty-five supplementary protection certificates in eleven countries.

Summary for Alcon

International Patents:18
US Patents:1
Tradenames:42
Ingredients:36
NDAs:46
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
DENDRID
idoxuridine
SOLUTION/DROPS;OPHTHALMIC014169-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985ATRXYesYes► Subscribe► Subscribe► Subscribe
Alcon
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
SUSPENSION/DROPS;OPHTHALMIC020619-001Apr 17, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
ECONOPRED
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017468-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
STATROL
neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC050344-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
MYDRIACYL
tropicamide
SOLUTION/DROPS;OPHTHALMIC012111-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062714-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
GENTAMICIN SULFATE
gentamicin sulfate
SOLUTION/DROPS;OPHTHALMIC062523-001Nov 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
BETADINE
povidone-iodine
SOLUTION/DROPS;OPHTHALMIC018634-001Dec 17, 1986RXYesYes► Subscribe► Subscribe► Subscribe
Alcon Pharma
ZADITOR
ketotifen fumarate
SOLUTION/DROPS;OPHTHALMIC021066-002Oct 19, 2006DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alcon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 2000► Subscribe► Subscribe
Alcon
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
SUSPENSION/DROPS;OPHTHALMIC020619-001Apr 17, 1997► Subscribe► Subscribe
Alcon
BSS PLUS
calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate
SOLUTION;IRRIGATION018469-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
Alcon Pharms Ltd
NAVSTEL
calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate
SOLUTION;IRRIGATION022193-001Jul 24, 2008► Subscribe► Subscribe
Alcon
VEXOL
rimexolone
SUSPENSION/DROPS;OPHTHALMIC020474-001Dec 30, 1994► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
Alcon
PROFENAL
suprofen
SOLUTION/DROPS;OPHTHALMIC019387-001Dec 23, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ALCON drugs

Drugname Dosage Strength Tradename Submissiondate
travoprost
Ophthalmic Solution0.00%
TRAVATAN
11/28/2008
ketotifen fumarate
Ophthalmic Solution0.03%
ZADITOR
12/23/2004

International Patent Family for Alcon Drugs

Country Document Number Estimated Expiration
South Africa200303557► Subscribe
Spain2339745► Subscribe
South Korea20070087252► Subscribe
Austria459337► Subscribe
TaiwanI290050► Subscribe
Portugal1343474► Subscribe
European Patent Office1343474► Subscribe
Australia2002239601► Subscribe
South Korea20030063441► Subscribe
Australia3960102► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Alcon Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
678Luxembourg► SubscribePRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
2012017Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
2015 00017Denmark► SubscribePRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720
2014029Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
/2015Austria► SubscribePRODUCT NAME: PHENYLEPHRIN, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND KETOROLAC, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1018 (MITTEILUNG) 20150730
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
C/GB03/033United Kingdom► SubscribePRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
2008006Lithuania► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Fish and Richardson
Healthtrust
Moodys
Citi
Julphar
McKinsey
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot